Obesity has become a serious global public health problem, and cardiomyopathy caused by obesity has recently gained attention. As an important protein involved in glucose and lipid metabolism, G protein-coupled receptor 40 (GPR40) exerts cardioprotective effects in some disease models. This study aimed to explore whether GPR40 plays a protective role in obesity-induced cardiomyopathy. We established an obesity model by feeding rats with a high-fat diet, and H9c2 cells were stimulated with palmitic acid to mimic high fat stimulation. Overexpression of GPR40 was achieved by infection with lentivirus or cDNA plasmids. Obesity-induced cardiac injury models exhibit cardiac dysfunction, myocardial hypertrophy, and collagen accumulation, which are accompanied by increased inflammation, oxidative stress, and apoptosis. However, GPR40 overexpression attenuated these alterations. The anti-inflammatory effect of GPR40 may be by inhibiting the nuclear factor-κB pathway, and the antioxidative stress may occur as a result of nuclear transcription factor erythroid 2-related factor 2 pathway activation. In terms of the mechanisms of GPR40 against obese cardiomyopathy, GPR40 overexpression not only activated the sirtuin 1 (SIRT1)-liver kinase B1 (LKB1)-AMP-activated protein kinase (AMPK) pathway but also enhanced the binding of SIRT1 to LKB1. The antifibrotic, anti-inflammatory, antioxidative stress, and antiapoptotic effects of GPR40 overexpression were inhibited by SIRT1 small interfering RNA. In conclusion, GPR40 overexpression protects against obesity-induced cardiac injury in rats, possibly through the SIRT1-LKB1-AMPK pathway.
Get full access to this article
View all access options for this article.
References
1.
HuangH, YanZ, ChenY, et al.A social contagious model of the obesity epidemic. Sci Rep, 2016; 6:37961.
2.
SoropO, OlverTD, van de WouwJ, et al.The microcirculation: a key player in obesity-associated cardiovascular disease. Cardiovasc Res, 2017; 113:1035–1045.
3.
VerbovoyAF, PashentsevaAV, SharonovaLA. [Obesity and cardiovascular system]. Klin Med (Mosk), 2017; 95:31–35.
4.
SeravalleG, GrassiG. Obesity and hypertension. Pharmacol Res, 2017; 122:1–7.
5.
PoirierP, GilesTD, BrayGA, et al.Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation, 2006; 113:898–918.
6.
AlpertMA, OmranJ, BostickBP. Effects of obesity on cardiovascular hemodynamics, cardiac morphology, and ventricular function. Curr Obes Rep, 2016; 5:424–434.
TiwariS, NdisangJF. The role of obesity in cardiomyopathy and nephropathy. Curr Pharm Des, 2014; 20:1409–1417.
9.
NagasumiK, EsakiR, IwachidowK, et al.Overexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice. Diabetes, 2009; 58:1067–1076.
10.
LinC, ChaoH, LiZ, et al.Omega-3 fatty acids regulate NLRP3 inflammasome activation and prevent behavior deficits after traumatic brain injury. Exp Neurol, 2017; 290:115–122.
11.
LiMH, ChenW, WangLL, et al.RLA8-A new and highly effective quadruple PPAR-α/γ/δ and GPR40 agonist to reverse nonalcoholic steatohepatitis and fibrosis. J Pharmacol Exp Ther, 2019; 369:67–77.
FuCN, SongJW, SongZP, et al.Excessive expression of miR-1a by statin causes skeletal injury through targeting mitogen-activated protein kinase kinase kinase 1. Aging, 2021; 13:11470–11490.
14.
LiangC, CurryBJ, BrownPL, et al.Leucine modulates mitochondrial biogenesis and SIRT1-AMPK signaling in C2C12 myotubes. J Nutr Metab, 2014; 2014:239750.
15.
LeaskA, AbrahamDJ. TGF-beta signaling and the fibrotic response. FASEB J, 2004; 18:816–827.
16.
LawrenceT. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol, 2009; 1:a001651.
17.
XiongJ, CaoX, QiaoS, et al.(Pro)renin receptor is involved in myocardial damage in alcoholic cardiomyopathy. Alcohol Clin Exp Res, 2019; 43:2344–2353.
18.
YuS, YuanH, YangM, et al.(Pro)renin receptor RNA interference silencing attenuates diabetic cardiomyopathy pathological process in rats. Hum Gene Ther, 2019; 30:727–739.
19.
AfshinA, ForouzanfarMH, ReitsmaMB, et al.Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med, 2017; 377:13–27.
QuinziDR. Obesity in children. Adv Nurse Pract, 1999; 7:46–50.
22.
LaniganJ, BarberS, SinghalA. Prevention of obesity in preschool children. Proc Nutr Soc, 2010; 69:204–210.
23.
ConklinA, TamA, YaoC, et al.Ethnic inequalities in cardiovascular disease risk: strength of ethnic identity predicts obesity prevalence in late adolescence. Heart Mind, 2018; 2:98–105.
24.
JiY, BaiC. Research progress of hypertriglyceridemia and coronary heart disease. Heart Mind, 2018; 2:40–44.
25.
WilliusFA, SmithHL. Factors concerned in cardiac hypertrophy: a study made at necropsy of seventy-nine cases of rheumatic heart disease. Am Heart J, 1934; 10:190–207.
26.
FrisbeeJC. Obesity, insulin resistance, and microvascular adaptation. Microcirculation, 2017; 24.
27.
VelezM, KohliS, SabbahHN. Animal models of insulin resistance and heart failure. Heart Fail Rev, 2014; 19:1–13.
28.
OuchiN, OhashiK, ShibataR, et al.Protective roles of adipocytokines and myokines in cardiovascular disease. Circ J, 2016; 80:2073–2080.
29.
van HoutGPJ, BoschL. The inflammasomes in cardiovascular disease. Exp Suppl, 2018; 108:9–40.
30.
BartekovaM, RadosinskaJ, JelemenskyM, et al.Role of cytokines and inflammation in heart function during health and disease. Heart Fail Rev, 2018; 23:733–758.
31.
CarvajalK, Balderas-VillalobosJ, Bello-SanchezMD, et al.Ca(2+) mishandling and cardiac dysfunction in obesity and insulin resistance: role of oxidative stress. Cell Calcium, 2014; 56:408–415.
32.
AlamMA, RahmanMM. Mitochondrial dysfunction in obesity: potential benefit and mechanism of Co-enzyme Q10 supplementation in metabolic syndrome. J Diabetes Metab Disord, 2014; 13:60.
33.
BoutagyNE, McMillanRP, FrisardMI, et al.Metabolic endotoxemia with obesity: is it real and is it relevant?. Biochimie, 2016; 124:11–20.
34.
SonaC, KumarA, DograS, et al.Docosahexaenoic acid modulates brain-derived neurotrophic factor via GPR40 in the brain and alleviates diabesity-associated learning and memory deficits in mice. Neurobiol Dis, 2018; 118:94–107.
35.
IxJH, SharmaK. Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. J Am Soc Nephrol, 2010; 21:406–412.
36.
García-PrietoCF, Gil-OrtegaM, AránguezI, et al.Vascular AMPK as an attractive target in the treatment of vascular complications of obesity. Vascul Pharmacol, 2015; 67–69:10–20.
37.
MarinoA, HausenloyDJ, AndreadouI, et al.AMP-activated protein kinase: a remarkable contributor to preserve a healthy heart against ROS injury. Free Radic Biol Med, 2021; 166:238–254.
38.
LiT, MuN, YinY, et al.Targeting AMP-activated protein kinase in aging-related cardiovascular diseases. Aging Dis, 2020; 11:967–977.
39.
MaoJY, SuLX, LiDK, et al.The effects of UCP2 on autophagy through the AMPK signaling pathway in septic cardiomyopathy and the underlying mechanism. Ann Transl Med, 2021; 9:259.
40.
AmmarHI, ShamseldeenAM, ShoukryHS, et al.Metformin impairs homing ability and efficacy of mesenchymal stem cells for cardiac repair in streptozotocin-induced diabetic cardiomyopathy in rats. Am J Physiol Heart Circ Physiol, 2021; 320:H1290–H1302.
41.
WangL, ZhaoD, TangL, et al.Soluble epoxide hydrolase deficiency attenuates lipotoxic cardiomyopathy via upregulation of AMPK-mTORC mediated autophagy. J Mol Cell Cardiol, 2020; 154:80–91.
42.
ZhuQ, HuF. Antagonism of miR-429 ameliorates anoxia/reoxygenation injury in cardiomyocytes by enhancing MO25/LKB1/AMPK mediated autophagy. Life Sci, 2019; 235:116842.
43.
WangK, HuangRL, WuSB, et al.[Effect of electroacupuncture preconditioning of “Neiguan”(PC6) on myocardial LKB1/AMPK/PFK2 pathway in myocardial ischemia rats]. Zhen Ci Yan Jiu, 2020; 45:99–104.
44.
LuQ, LiuJ, LiX, et al.Empagliflozin attenuates ischemia and reperfusion injury through LKB1/AMPK signaling pathway. Mol Cell Endocrinol, 2020; 501:110642.
45.
WangY, ZhuS, LiuH, et al.Thyroxine alleviates energy failure, prevents myocardial cell apoptosis, and protects against doxorubicin-induced cardiac injury and cardiac dysfunction via the LKB1/AMPK/mTOR axis in mice. Dis Markers, 2019; 2019:7420196.
46.
GrouixB, Sarra-BournetF, LeducM, et al.PBI-4050 reduces stellate cell activation and liver fibrosis through modulation of intracellular ATP levels and the liver kinase B1/AMP-activated protein kinase/mammalian target of rapamycin pathway. J Pharmacol Exp Ther, 2018; 367:71–81.
47.
GuL, CaiN, LyuY, et al.γ-Mangostin ameliorates free fatty acid-induced lipid accumulation via the SIRT1/LKB1/AMPK pathway in HepG2 and L02 cells. J Agric Food Chem, 2019; 67:13929–13938.
48.
Sandoval-RodriguezA, Monroy-RamirezHC, Meza-RiosA, et al.Pirfenidone is an agonistic ligand for PPARα and improves NASH by activation of SIRT1/LKB1/pAMPK. Hepatol Commun, 2020; 4:434–449.
49.
SharmaA, AnandSK, SinghN, et al.Berbamine induced activation of the SIRT1/LKB1/AMPK signaling axis attenuates the development of hepatic steatosis in high-fat diet-induced NAFLD rats. Food Funct, 2021; 12:892–909.
50.
ZhangY, JiangM, CuiBW, et al.P2X7 receptor-targeted regulation by tetrahydroxystilbene glucoside in alcoholic hepatosteatosis: a new strategy towards macrophage-hepatocyte crosstalk. Br J Pharmacol, 2020; 177:2793–2811.
51.
HanB, LvZ, HanX, et al.Harmful effects of inorganic mercury exposure on kidney cells: mitochondrial dynamics disorder and excessive oxidative stress. Biol Trace Elem Res, 2021.
52.
YangQ, HanB, LiS, et al.The link between deacetylation and hepatotoxicity induced by exposure to hexavalent chromium. J Adv Res, 2021; 35:129–140.
53.
LiY, WongK, GilesA, et al.Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21. Gastroenterology, 2014; 146:539–549.e7.
54.
YangD, YangQ, FuN, et al.Hexavalent chromium induced heart dysfunction via Sesn2-mediated impairment of mitochondrial function and energy supply. Chemosphere, 2021; 264:128547.
55.
LiS, ZhengX, ZhangX, et al.Exploring the liver fibrosis induced by deltamethrin exposure in quails and elucidating the protective mechanism of resveratrol. Ecotoxicol Environ Saf, 2021; 207:111501.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
